Publicly Released: February 3, 2020
The Office of National Drug Control Policy (ONDCP) Circular, “National Drug Control Program Agency Compliance Reviews,” October 22, 2019 (the Circular), requires each agency for which a Detailed Accounting Submission is required to provide a Performance Summary Report (the Report) to the Director of the Office of National Drug Control Policy, by February 1 of each year. The agency’s Chief Financial Officer or other accountable senior executive is required to provide the Report. The Circular requires the DoD Office of Inspector General (DoD OIG) to review the Report and express a conclusion on the reliability of each assertion made in the Report.
This report is the result of Proj. No. Project No. D2020-D000FT-0025.000